SHARON JOHNSON: Open Payments
NPI 1104951409 · RENSSELAER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 9 payments from 7 companies in 2025. Trend: 2023 $256 · 2024 $236 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $56 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Abbott Laboratories | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Philips North America LLC | 1 | $15 |
Products named: OTEZLA, Auvelity, REPATHA, VOQUEZNA, VRAYLAR, ID NOW INSTRUMENT, AIRSUPRA, Holter.
Industry payments across IN — which companies pay providers there.
